Amoy Diagnostics Co., Ltd.

SZSE:300685 Stock Report

Market Cap: CN¥8.2b

Amoy Diagnostics Management

Management criteria checks 3/4

Amoy Diagnostics' CEO is Jiemin Luo, appointed in Jan 2012, has a tenure of 13.33 years. directly owns 0.039% of the company’s shares, worth CN¥3.17M. The average tenure of the management team and the board of directors is 11.7 years and 3.8 years respectively.

Key information

Jiemin Luo

Chief executive officer

CN¥1.2m

Total compensation

CEO salary percentagen/a
CEO tenure13.3yrs
CEO ownership0.04%
Management average tenure11.7yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Is Amoy Diagnostics (SZSE:300685) A Risky Investment?

Mar 21
Is Amoy Diagnostics (SZSE:300685) A Risky Investment?

Amoy Diagnostics Co., Ltd.'s (SZSE:300685) Low P/E No Reason For Excitement

Jan 27
Amoy Diagnostics Co., Ltd.'s (SZSE:300685) Low P/E No Reason For Excitement

Estimating The Fair Value Of Amoy Diagnostics Co., Ltd. (SZSE:300685)

Jan 07
Estimating The Fair Value Of Amoy Diagnostics Co., Ltd. (SZSE:300685)

Amoy Diagnostics (SZSE:300685) Has A Rock Solid Balance Sheet

Dec 19
Amoy Diagnostics (SZSE:300685) Has A Rock Solid Balance Sheet

Amoy Diagnostics Co., Ltd.'s (SZSE:300685) Earnings Haven't Escaped The Attention Of Investors

Sep 18
Amoy Diagnostics Co., Ltd.'s (SZSE:300685) Earnings Haven't Escaped The Attention Of Investors

Are Investors Undervaluing Amoy Diagnostics Co., Ltd. (SZSE:300685) By 23%?

Aug 23
Are Investors Undervaluing Amoy Diagnostics Co., Ltd. (SZSE:300685) By 23%?

Amoy Diagnostics' (SZSE:300685) Upcoming Dividend Will Be Larger Than Last Year's

May 27
Amoy Diagnostics' (SZSE:300685) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Report: Amoy Diagnostics Co., Ltd. Missed Revenue Estimates By 6.1%

Apr 24
Earnings Report: Amoy Diagnostics Co., Ltd. Missed Revenue Estimates By 6.1%

Amoy Diagnostics (SZSE:300685) Could Easily Take On More Debt

Apr 18
Amoy Diagnostics (SZSE:300685) Could Easily Take On More Debt

What Amoy Diagnostics Co., Ltd.'s (SZSE:300685) 33% Share Price Gain Is Not Telling You

Mar 02
What Amoy Diagnostics Co., Ltd.'s (SZSE:300685) 33% Share Price Gain Is Not Telling You

Is Amoy Diagnostics Co., Ltd. (SZSE:300685) Worth CN¥22.0 Based On Its Intrinsic Value?

Mar 01
Is Amoy Diagnostics Co., Ltd. (SZSE:300685) Worth CN¥22.0 Based On Its Intrinsic Value?

CEO

Jiemin Luo (41 yo)

13.3yrs

Tenure

CN¥1,170,700

Compensation

Mr. Jiemin Luo has been General Manager of Amoy Diagnostics Co., Ltd. and served its Deputy General Manager and Secretary of The Board of Directors since January 2012. He has been Non-Independent Director...


Leadership Team

NamePositionTenureCompensationOwnership
Jiemin Luo
GM & Director13.3yrsCN¥1.17m0.039%
CN¥ 3.2m
Ying Chen
CFO, Accounting Supervisor & Secretary to the Board of Directors10yrsCN¥944.60k0.039%
CN¥ 3.2m
Ruan Li
Deputy GM16.8yrsCN¥904.20k0.039%
CN¥ 3.2m
Frank Ron Zheng
Deputy GM & Director3.8yrsCN¥1.59mno data
Huibin Zheng
Deputy General Managerno dataCN¥605.20k0.039%
CN¥ 3.2m
Hongyu Wang
Deputy General Managerno datano datano data

11.7yrs

Average Tenure

43.5yo

Average Age

Experienced Management: 300685's management team is seasoned and experienced (11.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jiemin Luo
GM & Director3.8yrsCN¥1.17m0.039%
CN¥ 3.2m
Ruan Li
Deputy GM2.3yrsCN¥904.20k0.039%
CN¥ 3.2m
Frank Ron Zheng
Deputy GM & Director3.8yrsCN¥1.59mno data
Li-Mou Zheng
Chairman17.3yrsCN¥615.20kno data
Enhua Wang
Independent Director3.8yrsCN¥120.00kno data
Qi Du
Non-Employee Supervisor3.8yrsno datano data
Jie Huang
Non-Employee Supervisor3.8yrsno datano data
Zhe Shen
Independent Directorless than a yearCN¥120.00kno data
Qiao Wu
Independent Directorless than a yearCN¥45.80kno data

3.8yrs

Average Tenure

46yo

Average Age

Experienced Board: 300685's board of directors are considered experienced (3.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/08 06:11
End of Day Share Price 2025/05/08 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Amoy Diagnostics Co., Ltd. is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yolanda YinChina Galaxy International Securities (Hong Kong)
Pei ChengChina Galaxy Securities Co., Ltd.
Ziyu HeChina International Capital Corporation Limited